Bobak R. Azamian
President/CEO and Board Chair at Tarsus Pharmaceuticals. Based in Irvine, California.
- Rank
- 1209th of 14,452
- Companies held
- 1
- Largest holding
- TARS, 100.0% of total
- Latest SEC filing
- Nov 13, 2026
What the $133M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals TARS Common Stock | Through the Bobak Azamian Living Trust established April 16, 2018 | 863,991 | $77.67 | $67.1M | 50.4% | Form 4, Dec 4, 2025 |
| Tarsus Pharmaceuticals TARS Common Stock | Through the Bobak Azamian Living Trust established April 16, 2018 | 817,991 | $77.67 | $63.5M | 47.7% | Form 4, Nov 13, 2026 |
| Tarsus Pharmaceuticals TARS Common Stock | Directly | 33,421 | $77.67 | $2.6M | 1.9% | Form 4, Nov 13, 2026 |
Share counts are the amounts Bobak R. Azamian reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Sold | TARS | 10,000 | $80.31 | $803K | View |
| Sep 4, 2026 | Sold | TARS | 2,900 | $91.27 | $265K | View |
| Sep 4, 2026 | Sold | TARS | 7,100 | $90.27 | $641K | View |
| Sep 2, 2026 | Sold | TARS | 10,000 | $80.06 | $801K | View |
| Jun 17, 2026 | Sold | TARS | 5,418 | $61.81 | $335K | View |
| Jun 17, 2026 | Sold | TARS | 4,582 | $61.24 | $281K | View |
| Mar 19, 2026 | Sold | TARS | 11,964 | $67.00 | $802K | View |
| Mar 18, 2026 | Sold | TARS | 11,667 | $68.71 | $802K | View |
| Mar 17, 2026 | Sold | TARS | 10,972 | $69.42 | $762K | View |
| Dec 24, 2025 | Sold | TARS | 5,443 | $82.41 | $449K | View |
| Dec 24, 2025 | Sold | TARS | 557 | $83.54 | $47K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1206 | Luc Jules R Tack Director, FMC | $133M |
| 1207 | Richard K. Smucker Insider, The J. M. Smucker. Orrville, OH | $133M |
| 1208 | Roger Jeffs Chief Executive Officer, Liquidia. Morrisville, NC | $133M |
| 1209 | Bobak R. Azamian President/CEO and Board Chair, Tarsus Pharmaceuticals. Irvine, CA | $133M |
| 1210 | Bradley Burnam Chief Executive Officer, Turn Therapeutics. Westlake Village, CA | $133M |
| 1211 | Andrew Dudum Chief Executive Officer, Hims & Hers Health. San Francisco, CA | $133M |
| 1212 | Ralph W. Shrader Director, Booz Allen Hamilton Holding. Mclean, VA | $133M |
Other Tarsus Pharmaceuticals insiders
All TARS insiders- Michael Ackermann$102MDirector. #1481 overall
- William J. Link Phd$8.2MDirector. #8038 overall
- Seshadri Neervannan$6.1MChief Operating Officer. #12566 overall
- Leonard Greenstein$2.1MChief Financial Officer. #13850 overall
- Bhaskar Chaudhuri$905KDirector. #4263 overall
- David E. I. Pyott$851KDirector. #9651 overall
Questions
How much stock does Bobak R. Azamian own?
Bobak R. Azamian holds $133,235,351 in listed stock based on SEC filings and current prices, mostly Tarsus Pharmaceuticals (TARS). That ranks 1209th on the Stock Rich List.
Is this Bobak R. Azamian's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Bobak R. Azamian last buy or sell stock?
The most recent open-market trade on file is a sale of 10,000 TARS shares on Nov 13, 2026 at $80.31.